{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:39:18Z","timestamp":1793263158036,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare gluconeogenic disorder characterized by hypoglycemia, lactic acidosis, hyperuricemia, and ketosis, triggered by fasting or infection. Although dietary management aims to prevent hypoglycemia, accurate tools to monitor asymptomatic episodes are lacking. Continuous glucose monitoring (CGM) has not been systematically evaluated in FBPase deficiency. This study aimed to assess the utility of CGM in detecting silent hypoglycemia and its relationship with dietary management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Ten genetically confirmed patients underwent blinded CGM using the Medtronic iPro2\u2122 system. CGM metrics included time below range (TBR &amp;lt;70 mg\/dL [&amp;lt;3.9 mmol\/L]), time in range (TIR 70\u2013150 mg\/dL [3.9\u20138.3 mmol\/L]), and time above range (TAR &amp;gt;150 mg\/dL [&amp;gt;8.3 mmol\/L]). Correlations with biochemical, clinical, and nutritional variables were analyzed using Pearson or Spearman tests, and categorical comparisons were conducted with Fisher\u2019s exact test. Multiple testing was controlled using the Benjamini\u2013Hochberg procedure (significance at FDR-adjusted p&amp;lt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite using uncooked\/modified cornstarch (UCCS\/MCS) and frequent feeding (all but one patient), asymptomatic hypoglycemia occurred in some patients. Mean TBR was 11.2 \u00b1 31.2% (Median: 1, Range:0-100). Higher UCCS\/MCS dosing correlated with fewer annual metabolic attacks (\u03c1=\u22120.854, p-adj=0.002), higher TIR (\u03c1=0.899, p-adj=0.002), and lower TBR (\u03c1=\u22120.917, p-adj=0.003). Patients with TBR\u22652% had more annual crises (p=0.003), lower UCCS\/MCS dosing frequency (p=0.019), and more hepatic steatosis (p=0.048). Ketonuria correlated with attack frequency (r=0.846, p-adj=0.026). Hepatosteatosis was associated with greater annual attacks (p-adj=0.028).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This, to the best of our knowledge, is the first systematic pilot study of CGM in FBPase deficiency, suggesting a potential role in detecting silent hypoglycemia and informing individualized dietary strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1664863","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:47Z","timestamp":1759983767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of continuous glucose monitoring for identifying silent hypoglycemia in fructose-1,6-bisphosphatase deficiency: a pilot prospective evaluation"],"prefix":"10.3389","volume":"16","author":[{"given":"Emine","family":"Goksoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Kumru Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-378630-2.00040-2","article-title":"Gluconeogenesis","volume-title":"Encyclopedia of Biological Chemistry","author":"Hanson","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2010.07.012","article-title":"Inborn errors of carbohydrate metabolism","volume":"24","author":"Mayatepek","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B3","article-title":"Fructose-1,6-bisphosphatase deficiency","volume-title":"GeneReviews","author":"Bijarnia-Mahay","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-018-0760-3","article-title":"International practices in the dietary management of fructose 1-6 biphosphatase deficiency","volume":"13","author":"Pinto","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.518","article-title":"Continuous glucose monitoring in conditions other than diabetes","volume":"20","author":"Maran","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1116864","article-title":"Continuous glucose monitoring for children with hypoglycemia: Evidence in 2023","volume":"14","author":"Worth","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-024-09903-y","article-title":"Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications","volume":"25","author":"Gugelmo","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013996325720","article-title":"Continuous glucose monitoring in children with glycogen storage disease type I","volume":"24","author":"Hershkovitz","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12383","article-title":"A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management","volume":"44","author":"Peeks","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2013.186","article-title":"Continuous glucose monitoring in children with glycogen storage disease type i","volume":"68","author":"Kasapkara","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-1209-3861","article-title":"Experience with real-time continuous glucose monitoring in newborns with congenital hyperinsulinemic hypoglycemia","volume":"225","author":"An\u0131k","year":"2021","journal-title":"Z Geburtshilfe Neonatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0070","article-title":"Comparison of accuracy of freestyle libre pro and medtronic iPro2 continuous glucose monitoring systems in pregnancy","volume":"25","author":"Golla","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221110830","article-title":"Use of continuous glucose monitors by people without diabetes: an idea whose time has come","volume":"17","author":"Klonoff","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12386","article-title":"A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net","volume":"44","author":"Rossi","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac060","article-title":"Continuous glucose monitoring profiles in healthy, nondiabetic young children","volume":"6","author":"Dubose","year":"2022","journal-title":"J Endocr Soc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: A multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400226","article-title":"Professional continuous glucose monitoring in clinical practice","volume":"4","author":"Blevins","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac411","article-title":"A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: toward glycemic targets","volume":"107","author":"Rossi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-9034-5","article-title":"Fructose 1,6-bisphosphatase deficiency: Enzyme and mutation analysis performed on calcitriol-stimulated monocytes with a note on long-term prognosis","volume":"33","author":"\u00c5sberg","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"B20","first-page":"1","article-title":"Fructose-1,6-diphosphatase deficiency in Israel","volume":"27","author":"Moses","year":"1991","journal-title":"Isr J Med Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9335-3","article-title":"The use of continuous glucose monitoring in the practical management of glycogen storage disorders","volume":"34","author":"White","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108573","article-title":"Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study","volume":"143","author":"Overduin","year":"2024","journal-title":"Mol Genet Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101136","DOI":"10.1016\/j.ymgmr.2024.101136","article-title":"Intrafamilial phenotypic variability due to a missense pathogenic variant in FBP1 gene","volume":"41","author":"Dalili","year":"2024","journal-title":"Mol Genet Metab Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1664863\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:48Z","timestamp":1759983768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1664863\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":23,"alternative-id":["10.3389\/fendo.2025.1664863"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1664863","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"article-number":"1664863"}}